A Risky Business: Why Do Some Parkinson's Disease Treatments Affect Decision Making? Sep. 24, 2024 — Parkinson's disease, a debilitating nervous system disorder, is treated with medications that ...

Some Diabetes Drugs Tied to Lower Risk of Dementia, Parkinson's Disease Sep. 18, 2024 — A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease ...

A national Parkinson’s disease charity is offering up to £3,000 in grant funding for any communities ... Physical activity ...

Joy Milne is a "super smeller" with a hyper-sensitive sense of smell, which allowed her to detect her husband's Parkinson's ...

John Rzeznik, Brian Fallon, Pete Steinkopf, Dramarama, Willie Nile, Joe Grushecky and the Houserockers and more set for Bob's ...

Aspen Neuroscience Chief Financial Officer Kameel Farag will present company updates in a fireside chat today at 4:15 pm PT at the UBS Global Healthcare Conference in Rancho Palos Verdes, Calif., ...

Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science research, diagnostic, therapeutic development, and precision medicine applications, ...

Gene variant found linking people of African descent to higher Parkinson’s risk One million Americans live with Parkinson’s disease, a progressive condition that causes problems with body ...

AbbVie has finally claimed FDA approval for its advanced Parkinson's disease therapy Vyalev, 18 months after the US regulator turned it down with a request for more data. Now, Vyalev (foscarbidopa ...

A small study of Sanofi’s lixisenatide has suggested that the GLP-1 agonist could slow down the progression of Parkinson’s disease, pointing to another potential use for the fast-growing drug ...

(WDRB) -- Norton Healthcare's Neuroscience Institute will soon ... ultrasound for essential tremor and tremor-dominant Parkinson’s disease, according to a news release. The procedure, which ...